FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
Horizon Pharma plc (Nasdaq: HZNP) announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for U.S. patent application number 14/958,259, entitled "Methods of Therapeutic Monitoring of Nitrogen Scavenging Drugs" that covers Horizon's U.S. approved medicine RAVICTI®... More

